Merit Medical Systems Acquires Biolife Delaware

Agilent Technologies Acquires Biocare Medical

March 9, 2026

Medical Devices

Agilent Technologies entered into a definitive agreement to acquire Biocare Medical, a global provider of clinical and research pathology solutions, for $950 million in an all-cash transaction. The acquisition expands Agilent’s pathology portfolio—particularly in immunohistochemistry (IHC)—and is expected to be accretive to Agilent’s top-line growth rate, margin profile, and non-instrument revenue mix in Year 1.

BioStem Technologies Acquires BioTissue's Surgical and Wound Care Business

January 22, 2026

Medical Devices

BioStem Technologies (OTC: BSEM) has acquired the surgical and wound care business of BioTissue Holdings, Inc. for approximately $15 million upfront, with up to $25 million of contingent milestone and royalty payments. The deal includes the Neox and Clarix product lines, a nationwide commercial sales organization and assigned GPO contracts, expanding BioStem's access into hospital inpatient and outpatient wound-care markets and adding assets that generated roughly $29 million in 2025.

LifeNet Health Acquires HCM Medical

August 20, 2025

Biotechnology

LifeNet Health has acquired HCM Medical, a Netherlands‑based contract manufacturing organization (CMO) specializing in biologics and tissue‑processing technologies. The deal expands LifeNet Health's manufacturing capabilities in regenerative biologics — including xenograft platforms, antibiotic‑coated implants, and advanced sterilization — to accelerate global access to advanced therapies.

Marketlab Acquires Assets of Medi‑Tech International Corporation

September 12, 2023

Medical Devices

Marketlab, a family-owned manufacturer of specialty healthcare products based in Caledonia, Michigan, has acquired the assets of Medi‑Tech International Corporation, a Brooklyn, New York‑based manufacturer of wound care, labor‑and‑delivery, and patient safety products. The acquisition expands Marketlab’s medical‑surgical and laboratory product portfolio and brings additional products, distribution partnerships, and GPO contracts into its offering to better serve IDNs and other healthcare customers.

Pace Life Sciences Acquires Meridian BioGroup

August 18, 2022

Healthcare Services

Pace Life Sciences, a CDMO and subsidiary of Pace Science and Technology Company, has acquired Meridian BioGroup, a validation, regulatory, and compliance consulting provider based in Frederick, Maryland. The deal expands Pace's regulatory, quality and validation capabilities to better support biotechnology and pharmaceutical clients across development and commercialization.

Mountaingate Capital Acquires BioDerm

January 11, 2021

Medical Devices

Denver-based private equity firm Mountaingate Capital has acquired BioDerm, Inc., a Largo, Florida manufacturer of disposable medical devices and wound care supplies, in a transaction supported by subordinated debt and an equity co-investment from Five Points Capital and additional financing from Abacus Finance Group. Mountaingate said it will accelerate BioDerm's organic growth and pursue add-on acquisitions to expand product and service offerings while management and founder shareholders retain a continued ownership/board role.